PLx Pharma (NSDQ:PLXP) announced today that it priced an underwritten public offering worth approximately $63 million.
Sparta, N.J.-based PLx Pharma is offering 7.875 million shares of its common stock priced at $8 per share to the public, according to a news release.
Get the full story at our sister site, Drug Delivery Business News.